Erbliche Erkrankungen mit heterotroper Knochenbildung ist eine Gruppe von erkrankungen, wo sich normales Knowchengewebe außerhalb des Skelettes bildet. Meist ist zudem das Körperskelett deformiert.
1. |
Shore EM et al. (2002) Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. |
2. |
Rogers JG et al. (1979) Paternal age effect in fibrodysplasia ossificans progressiva. |
3. |
Tünte W et al. (1967) [On the genetics of myositis ossificans progressiva]. |
4. |
Connor JM et al. (1982) Genetic aspects of fibrodysplasia ossificans progressiva. |
5. |
Schroeder HW et al. (1980) The hand and foot malformations in fibrodysplasia ossificans progressiva. |
6. |
Kaplan FS et al. (1993) The histopathology of fibrodysplasia ossificans progressiva. An endochondral process. |
7. |
Kaplan FS et al. (1993) Genetic transmission of fibrodysplasia ossificans progressiva. Report of a family. |
8. |
Connor JM et al. (1993) A three generation family with fibrodysplasia ossificans progressiva. |
9. |
Cohen RB et al. (1993) The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients. |
10. |
Janoff HB et al. (1996) Fibrodysplasia ossificans progressiva in two half-sisters: evidence for maternal mosaicism. |
11. |
Beratis NG et al. (1976) Alkaline phosphatase activity in cultured skin fibroblasts from fibrodysplasia ossificans progressiva. |
12. |
Bastepe M et al. (2005) GNAS locus and pseudohypoparathyroidism. |
13. |
Stoll C et al. () Progressive osseous heteroplasia: an uncommon cause of ossification of soft tissues. |
14. |
Eddy MC et al. (2000) Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification. |
15. |
Shimono K et al. (2011) Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists. |
16. |
Faust RA et al. (2003) Progressive osseous heteroplasia in the face of a child. |
17. |
Izraeli S et al. (1992) Albright hereditary osteodystrophy with hypothyroidism, normocalcemia, and normal Gs protein activity: a family presenting with congenital osteoma cutis. |
18. |
Adegbite NS et al. (2008) Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification. |
19. |
Gardner RJ et al. (1988) Familial ectopic ossification. |
20. |
Brook CG et al. (1971) Osteoma cutis and Albright's hereditary osteodystrophy. |
21. |
MacLean GD et al. (1966) Connective tissue ossification presenting in the skin. |
22. |
Fawcett HA et al. (1983) Hereditary osteoma cutis. |
23. |
Rosenfeld SR et al. (1995) Progressive osseous heteroplasia in male patients. Two new case reports. |
24. |
Athanasou NA et al. () Progressive osseous heteroplasia: a case report. |
25. |
Kaplan FS et al. (1994) Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases. |
26. |
Schmidt AH et al. (1994) Hemimelic progressive osseous heteroplasia. A case report. |
27. |
Urtizberea JA et al. (1998) Progressive osseous heteroplasia. Report of a family. |
28. |
Xu MQ et al. (2002) Reported noggin mutations are PCR errors. |
29. |
Lin GT et al. (2006) De novo 617G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva. |
30. |
Nakajima M et al. (2007) The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva. |
31. |
Furuya H et al. (2008) A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). |
32. |
Bocciardi R et al. (2009) Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. |
33. |
Kaplan FS et al. (2009) Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. |
34. |
Petrie KA et al. (2009) Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients. |
35. |
Barnett CP et al. (2011) Late-onset variant fibrodysplasia ossificans progressiva leading to misdiagnosis of ankylosing spondylitis. |
36. |
Smith R et al. (1976) Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment. |
37. |
Kan L et al. (2004) Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. |
38. |
Shafritz AB et al. (1996) Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. |
39. |
Lucotte G et al. (1999) A de novo heterozygous deletion of 42 base-pairs in the noggin gene of a fibrodysplasia ossificans progressiva patient. |
40. |
Xu MQ et al. (2000) Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva (FOP). |
41. |
Sémonin O et al. (2001) Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. |
42. |
Shore EM et al. (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. |
43. |
None (2002) Significant difference of opinion regarding the role of noggin in fibrodysplasia ossificans progressiva. |
44. |
Fontaine K et al. (2005) A new mutation of the noggin gene in a French Fibrodysplasia ossificans progressiva (FOP) family. |
45. |
Lucotte G et al. (2007) Mutations of the noggin and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP). |
46. |
Feldman G et al. (2000) Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31. |
47. |
Lucotte G et al. (2000) Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22. |
48. |
Rogers JG et al. (1979) Fibrodysplasia ossificans progressiva. A survey of forty-two cases. |
49. |
Maxwell WA et al. (1977) Histochemical and ultrastructural studies in fibrodysplasia ossificans progressiva (myositis ossificans progressiva). |
50. |
Daltroff G et al. (1992) [Fibromatosis and fibrodysplasia ossificans progressiva. An avoidable diagnostic error]. |
51. |
de la Peña LS et al. (2005) Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. |
52. |
Kitterman JA et al. (2005) Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. |
53. |
Seemann P et al. (2008) The tale of FOP, NOGGIN and myristoylation: no data, no proof! |
54. |
Kaplan FS et al. (2008) Response to "Mutations of the NOGGIN and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP)" by Lucotte et al. |